A boardroom reshuffle at pharmaceutical business
long-serving CFO Angus Russell appointed as chief executive.
Russell, who took the CFO role in 1999, takes on the top job in place of
Matthew Emmens – who moves to chairman.
He has served in the pharmaceutical industry for 27 years including his time
as Shire CFO, with roles at ICI, Zeneca and its successor business AstraZeneca.
Shire said it had met with corporate governance recommendations in the
combined Code in terms of appointing the former chief executive as chairman, by
consulting on the issue with shareholders.
‘As required by the UK Combined Code on Corporate Governance, these
appointments have been discussed in advance with major shareholders and
representatives of a shareholder representative body,’ the company said in a
Former chairman Dr James Cavanaugh has retired.
Pharmaceutical firm revamps
intranet to improve data access
Mark McMullen joins the private client services team from Smith & Williamson
Merger between Clear & Lane Chartered Accountants and Magma Chartered Accountants was finalised on 3 February
BDO has taken its new partner intake to 23 during the first half of its financial year, including the appointment of five partners in five weeks
The firm reports 7.6% global fee income growth for the year ending 31 December 2016